A detailed history of Prelude Capital Management, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Prelude Capital Management, LLC holds 3,512 shares of TECH stock, worth $256,481. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,512
Previous 3,512 -0.0%
Holding current value
$256,481
Previous $280,000 -0.0%
% of portfolio
0.02%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$70.96 - $82.35 $1.12 Million - $1.3 Million
-15,810 Reduced 81.82%
3,512 $280,000
Q2 2024

Aug 14, 2024

SELL
$62.12 - $84.15 $407,134 - $551,519
-6,554 Reduced 25.33%
19,322 $1.38 Million
Q1 2024

May 15, 2024

BUY
$65.98 - $77.09 $955,522 - $1.12 Million
14,482 Added 127.1%
25,876 $1.82 Million
Q4 2023

Feb 14, 2024

BUY
$52.83 - $78.22 $243,176 - $360,046
4,603 Added 67.78%
11,394 $879,000
Q3 2023

Nov 14, 2023

BUY
$67.52 - $89.42 $458,528 - $607,251
6,791 New
6,791 $462,000
Q4 2021

Feb 14, 2022

SELL
$456.15 - $525.06 $496,747 - $571,790
-1,089 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$444.87 - $538.88 $484,463 - $586,840
1,089 New
1,089 $528,000
Q1 2021

May 17, 2021

SELL
$314.62 - $411.0 $480,110 - $627,186
-1,526 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$246.9 - $321.87 $376,769 - $491,173
1,526 New
1,526 $485,000
Q3 2018

Nov 14, 2018

SELL
$147.44 - $204.11 $29,488 - $40,822
-200 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$144.9 - $165.58 $28,980 - $33,116
200 New
200 $30,000
Q4 2017

Feb 14, 2018

SELL
$121.17 - $134.75 $312,618 - $347,655
-2,580 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$113.59 - $123.78 $293,062 - $319,352
2,580
2,580 $312,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.86B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.